INSIGHTS ON PHARMA LOGISTICS

  • Ensuring The Efficacy Of Probiotic Products
    Ensuring The Efficacy Of Probiotic Products

    There is growing interest among consumers in verifying that the dietary supplements they take are safe and efficacious. The concern over whether consumers are getting the product as it is described on the label is rooted in one vital and transformative fact: probiotics are living organisms that are highly sensitive to humidity and oxygen. In the absence of proper handling and packaging, the efficacy of probiotic products can be compromised at any point of the packaging, storage and transportation process, inversely impacting shelf life and product viability and efficacy for the consumer.

  • Clinical Trial Packaging, Labeling And Storage In Horsham, UK
    Clinical Trial Packaging, Labeling And Storage In Horsham, UK

    This video provides insight into Thermo Fisher Scientific’s primary and secondary packaging of clinical trial materials at the Horsham, UK site. This site also specializes in automated global distribution and in Cold Chain Management.

  • "Validation" Or "Qualification" – What’s The Difference?
    "Validation" Or "Qualification" – What’s The Difference?

    What is the difference between qualification and validation? This question comes up frequently with both internal and external clients. 

  • Storing Biologics At Non-Traditional Temperatures
    Storing Biologics At Non-Traditional Temperatures

    Maintaining the appropriate storage temperature of biological material is critical for downstream use. However, due to the complexity of this material and its sensitivity to temperature we are seeing an increase in non-traditional storage temperature requests. In this article, we’ll explore some of the reasons why this is occurring and the associated challenges.

  • Managing Refrigerated vs. Frozen Drug Product: What’s The Big Deal?

    The most common storage is ultra-low temperature storage, but the fastest-growing is cryogenic, in vapor phase liquid nitrogen. This transition is huge. Chain of temperature data and chain of custody in handling is imperative to the pharmaceutical industry of today.  These additional factors partly explain the much higher cost of these therapies as well. The three primary issues are: capacity, regulatory, and risk. We’ll look briefly at all three.

  • Top Considerations To Meet FDA Requirements For Packaging Cryogenically Frozen Advanced Therapies

    US Food and Drug Administration (FDA) requirements specify that packaging and distribution systems must protect the agent from contamination and damage. In distributing cryogenically frozen advanced therapies, this includes protection from temperature shock.

  • The Importance Of Inventory Management: Do You Know Where Your Samples Are?

    With the exciting advances in research and drug development, the importance of sample management has never been higher. If you have ever experienced sample management mishaps, we ask: Do you know where your samples are? In this article, we’ll explore some of the common causes of inventory mismanagement and best practices to guard against sample loss and near misses.

  • Managing Risks To Time Critical Product Imports At Clinical Supply Depots

    Global regulatory standards for clinical trials are, simply put, complex. In this case study, learn how one company worked with its partner to overcome the challenge of a protocol based in the US, an investigational medical product (IMP) approved in the EU, and varying QP (qualified person) rules from country to country, to conduct their clinical trial in Isreal.

More Insights On Pharma Logistics

PHARMA LOGISTICS SOLUTIONS

  • Ibex™ Design

    The demand for biopharmaceutical products is continuously growing to serve the needs of an aging global population and the prevalence of chronic diseases. At the same time, the environment for biopharma companies is complex and challenging, with novel regulatory pathways, requirements to accelerate patient access, and rising competition.

  • Brochure: Chemical Synthesis: Small Molecule API Manufacturing

    Chemical synthesis for small molecule manufacturing is one of Lonza's key competencies. While many manufacturers focus their attention exclusively on biologics, Lonza recognizes that chemistry still represents 70% to 80% of the drugs on the market and in late-phase development.

  • Specialty Courier Fact Sheet

    This fact sheet offers insight into our logistics solutions for high value/high risk shipments. Download it to learn more about our consultative solution design focused on defining client and situation-specific solutions, driving cost savings, and reducing time-in-transit.

  • Brochure: Cell Therapy: Development & Manufacturing

    Lonza is the industry leader in development, manufacturing and commercialization services for cell-based therapeutics.

  • Your Trusted Packaging And Serialization Partner

    How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.

More Pharma Logistics Solutions

INDUSTRY EVENTS

Electronic Data Integrity in a GxP Environment: Managing the Data Lifecycle for Compliance November 20 - 20, 2019
1pm-2:30pm EST, Online Training
Price:  $299 - Includes Bonus Handouts!
Establishing Appropriate Quality Metrics November 21 - 21, 2019
1pm-2:30pm EST, Online Training
Duration:  90-Minutes
Price:  $299 - Includes Bonus Handouts!
Environmental Monitoring (EM) – Establishing and Improving Programs Using a Risk-based Approach December 5 - 5, 2019
1pm-2:30pm EST, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Essentials of Disinfectant Efficacy Testing – Ensuring Microbial Control December 12 - 12, 2019
1pm-2:30pm EST, Online Training
Duration:  90-Minutes
Price:  $299 - Includes Bonus Handouts!